Renal association clinical practice guideline on prevention of blood borne virus infection in the renal unit

Nephron - Clinical Practice

Volumn 118, Issue SUPPL. 1, 2011, Pages

  Geddes, Colin ^a   Lindley, Elizabeth ^b   Duncan, Neill ^c  

^a NHS GREATER GLASGOW AND CLYDE   (United Kingdom)

^b LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

^c IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

Author keywords

Blood borne virus; dialysis patients; hepatitis B; hepatitis C; universal precautions

Indexed keywords

HEPATITIS B VACCINE; RECOMBINANT HEPATITIS B VACCINE;

ARTICLE; CHRONIC KIDNEY DISEASE; DIALYSIS; HEPATITIS B; HEPATITIS C; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; INFECTION PREVENTION; INFECTION RISK; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; RENAL REPLACEMENT THERAPY;

BLOOD-BORNE PATHOGENS; GREAT BRITAIN; HEMODIALYSIS UNITS, HOSPITAL; HEPATITIS, VIRAL, HUMAN; HIV INFECTIONS; HUMANS; KIDNEY FAILURE, CHRONIC; NATIONAL HEALTH PROGRAMS; PRACTICE GUIDELINES AS TOPIC; SOCIETIES, MEDICAL;

EID: 79955872470     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000328068     Document Type: Article

References (7)

1. Strader DB,Wright T, Thomas DL, Seeff LB. Diagnosis, management, and treatment of hepatitis C. Hepatology 2004;39:1147-1171 (Pubitemid 38428955)
2. Minuk GY, Sun DF, Greenberg R et al. Occult hepatitis B virus infection in a North American adult hemodialysis patient population. Hepatology 2004;40:1072-1077 (Pubitemid 39425562)
3. Liu CJ, Chen DS, Chen PJ. Epidemiology of HBV infection in Asian blood donors: emphasis on occult HBV infection and the role of NAT. J Clin Virol 2006;36 Suppl 1:S33-S44
4. Liu CJ, Kao JH, Chen DS. Molecular assays for hepatitis B virus infection. Hepatology 2003;38:1311
5. Rahnavardi M, Hosseini Moghaddam SM, Alavian SM. Hepatitis C in hemodialysis patients: current global magnitude, natural history, diagnostic difficulties, and preventive measures. Am J Nephrol 2008; 28:628-640 (Pubitemid 351832450)
6. Courouce AM, Le Marrec N, Bouchardeau F et al. Efficacy of HCV core antigen detection during the preseroconversion period. Transfusion 2000;40:1198-1202
7. Fabrizi F, de Vecchi AF, Como G et al. De novo HCV infection among dialysis patients: a prospective study by HCV core antigen ELISA assay. Alimentary Pharmacology & Therapeutics 2005;21:861-869 (Pubitemid 40477246)